Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles
Open Access
- 26 April 2020
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 10 (5), 173
- https://doi.org/10.3390/metabo10050173
Abstract
Triple-negative breast cancer (TNBC) is characterized by limited survival, poor prognosis, and high recurrence. Understanding the metabolic adaptations of TNBC could help reveal improved treatment regiments. Here we performed a comprehensive 1H NMR metabolic characterization of the MDA-MB-468 cell line, a commonly used model of TNBC, followed by an analysis of serum samples obtained from TNBC patients and healthy controls. MDA-MB-468 cells were cultured, and changes in the metabolic composition of the medium were monitored for 72 h. Based on time courses, metabolites were categorized as being consumed, being produced, or showing a mixed behavior. When comparing TNBC and control samples (HC), and by using multivariate and univariate analyses, we identified nine metabolites with differing profiles). The serum of TNBC patients was characterized by higher levels of glucose, glutamine, citrate, and acetoacetate and by lower levels of lactate, alanine, tyrosine, glutamate, and acetone. A comparative analysis between MDA-MB-468 cell culture media and TNBC patients’ serum identified a potential systemic response to the carcinogenesis-associated processes, highlighting that MDA-MB-468 cells footprint does not reflect metabolic changes observed in studied TNBC serum fingerprint.This publication has 52 references indexed in Scilit:
- Single-platform ‘multi-omic’ profiling: unified mass spectrometry and computational workflows for integrative proteomics–metabolomics analysisMolecular Omics, 2018
- 5 year Overall survival of triple negative breast cancer: A single institution experience.Journal of Clinical Oncology, 2016
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white womenCA: A Cancer Journal for Clinicians, 2015
- Integration of omics sciences to advance biology and medicineClinical Proteomics, 2014
- Cell MetabolomicsOMICS: A Journal of Integrative Biology, 2013
- Spheroid culture as a tool for creating 3D complex tissuesTrends in Biotechnology, 2013
- Absolute quantification of metabolites in breast cancer cell extracts by quantitative 2D 1H INADEQUATE NMRNMR in Biomedicine, 2012
- Translating cancer ‘omics’ to improved outcomes: Figure 1.Genome Research, 2012
- Real time monitoring of multiple parameters in mammalian cell culture bioreactors using an in‐line Raman spectroscopy probeBiotechnology & Bioengineering, 2010
- A Review of Triple-Negative Breast CancerCancer Control, 2010